The Rel/NF-kB family of transcription factors controls the expression of a wide variety of genes that are implicated in immune and in¯ammatory responses and cellular proliferation. Disregulation of NF-kB is associated with cellular transformation and the maintenance of a high anti-apoptotic threshold in transformed cells. NF-kB activity is in turn regulated by its sequestration in the cytoplasm by the inhibitor IkB. IkBa, the most abundant and well-characterized member of the IkB multiprotein family, is rapidly degraded in response to multiple physiologic stimuli. In the present study we show that not only the amino-terminus, but also the carboxy-terminus of IkBa contain transferable signals that must be simultaneously present in an unrelated protein to render it susceptible to activation-induced, proteasome-mediated degradation. We show here that IkBa amino-terminal modi®cations occur independently of the carboxy-terminus. Moreover, we present evidence indicating a critical role for the carboxy-terminal region in facilitating proteolysis by the catalytic core of the proteasome. When incubated with 20S proteasome extracted from rat liver, IkBa was quickly degraded while a deletion mutant lacking the carboxy-terminus was resistant to proteolysis. Likewise, chimeric proteins of beta-galactosidase with the IkBa carboxy-terminus were degraded in vitro independently of the presence of the IkBa amino-terminus, whereas chimeric proteins lacking the IkBa carboxy-terminus were stable. Our results identify the carboxy-terminus of IkBa as a domain critical for degradation through interaction with an as yet unidenti®ed component of the proteasome.
Introduction
The Rel/NF-kB (NF-kB) family of tanscription factors is implicated in the activation of a wide variety of cellular and viral genes, including genes involved in immune and in¯ammatory responses, and cellular proliferation (reviewed by Roulston et al., 1995; Baldwin, 1996; Baeuerle and Baltimore, 1996) . Furthermore, deregulation of NF-kB activity is associated with cellular transformation. Increased NF-kB activity induced by the HTLV-1 Tax transactivator protein has been implicated in the transformation of murine ®broblasts (reviewed in Verma et al., 1995) . Additionally, it has been shown that NF-kB blocks apoptosis in transformed cells and is involved in the maintenance of a high anti-apoptotic threshold in tumor cells, accounting for enhanced resistance to anti-tumoral agents (Beg and Baltimore, 1996; Wang et al., 1996; Van Antwerp et al., 1996a) .
In unstimulated cells the transcription factor NF-kB is sequestered in the cytoplasm as a latent, inactive complex containing the inhibitor protein IkBa. Activation of NF-kB involves signal-induced degradation of IkBa and release of NF-kB which translocates to the nucleus where it in¯uences transcription. The activation of NF-kB transcription factors is controlled by the IkB family of inhibitor proteins which feature ankyrin repeat domains, and by phosphorylation at a PKA consensus site in RelA (Zhong et al., 1997) . IkB proteins control both nuclear translocation and DNA binding of NF-kB proteins (Gilmore and Morin, 1993; Matthews and Hay, 1995) . Several IkB species have been reported in vertebrates: IkBa, IkBb, IkBg (p105 C-terminal region), IkB-d (p100 C-terminal region), IkB-e, and Bcl-3. The molecular mechanisms responsible for the inactivation of these inhibitors, a process resulting in NF-kB activation, are in general poorly understood. Most information is available on the IkBa pathway.
IkBa has a tripartite organization consisting of a 170 amino acid central region (aa 73 ± 242) with the ®ve ankyrin repeats domain (ARD), an unstructured 72 amino acid N-terminal region (aa 1 ± 72) also called signal response domain (SRD), and a carboxy-terminal region (aa 243 ± 317) encompassing a 42 amino acid, highly acidic domain (aa 276 ± 317) attached to the ARD of the protein by a 33 amino acid proteasesensitive linker (aa 243 ± 275) which is protected by bound p65 (Jaray et al., 1995) . The highly acidic domain contains a PEST (rich in proline, glutamid acid, serine and threonine) region (Rogers and Rechsteiner, 1986) . This kind of sequence has been implicated in the proteolysis of several cellular proteins (reviewed by Rechsteiner and Rogers, 1996) . Mutational analysis has shown that both the ankyrin repeats and acidic domains are required for the inhibitory activity of IkB proteins (Hatada et al., 1993; Naumann et al., 1993; Barroga et al., 1995) .
Following signal induction, IkBa is rapidly phosphorylated and degraded (Beg and Baldwin, 1993; Henkel et al., 1993; Mellits et al., 1993) . IkBa phosphorylation induced by cell-activation signals does not disrupt NF-kB/IkBa complexes (Finco et al., 1994; Miyamoto et al., 1994; Sun et al., 1994; Traenckner et al., 1994; Alkalay et al., 1995; DiDonato et al., 1995; Lin et al., 1995) . Upon IkBa degradation, NF-kB is released and translocates to the nucleus where it induces the transcription of the IkBa gene (LeBail et al., 1993; Sun et al., 1993; Chiao et al., 1994) . Resynthesized IkBa accumulates transiently in the nucleus where it negatively regulates NF-kB dependent transcription and promotes export of the transcription factor out of the nucleus (Arenzana-Seisdedos et al., 1997) .
Speci®c inhibition of the proteolytic activity of the proteasome prevents NF-kB activation and promotes the accumulation of both hyperphosphorylated and ubiquitinated forms of IkBa (Ro et al., 1996) . Point mutation analyses indicate that the amino-terminal residues Ser-32 and Ser-36 are the sites of inducible phosphorylation Brown et al., 1995; Traenckner et al., 1995; DiDonato et al., 1996) and that combined mutation of Ser-32 and Ser-36 prevents ubiquitination of the molecule. Similar analyses have proven that Lys-21 and Lys-22, as principal residues,and Lys-38 and Lys-47, as secondary residues, are the sites of the covalent attachment of multiubiquitin chains Baldi et al., 1996; Rodriguez et al., 1996) , a modi®cation which ultimately targets IkBa for degradation by the proteasome. Thus, signal-induced modi®cation of the NH 2 terminus of IkBa by a phosphorylation-dependent, ubiquitin-mediated process is necessary for the activation of NF-kB Alkalay et al., 1995; Li et al., 1995; Ro et al., 1996) . Indeed, serine or lysine mutations which prevent either signal-induced phosphorylation or ubiquitination make the protein resistant to proteolysis and confer on IkBa the properties of a transdominant-negative inhibitor of NF-kB-dependent transcription Brown et al., 1995; Traenckner et al., 1995; Rodriquez et al., 1996) . Such IkBa mutants abrogate the antiapoptotic eect of NF-kB in transformed cells, rendering them more susceptible to anti-cancer agents (Wang et al., 1996; Van Antwerp et al., 1996a) .
In contrast to the signal-induced phosphorylation of the NH 2 terminus, phosphorylation of the COOH domain mediated by casein kinase II is constitutive and does not require cell activation (Janosch et al., 1996; Lin et al., 1996; McElhinny et al., 1996; Schwarz et al., 1996) . The serine and threonine residues phosphorylated by casein kinase II are located in the PEST domain, and mutation of these sites impairs the basal turnover of the protein (Barroga et al., 1995; Lin et al., 1996) . Deletion of the COOH terminus of IkBa renders the protein refractory to signal-induced, proteasomemediated degradation (Brown et al., 1995; Rodriquez et al., 1995; Whiteside et al., 1995; Sun et al., 1996) . Thus, it appears that besides the signal-induced modi®cations of the NH 2 terminus, the COOH domain also contains still unde®ned degradation signals required for inducible proteolyis of IkBa. Furthermore, both sets of signals must be simultaneously expressed to permit IkBa degradation in response to cell activation.
The objective of this work was to de®ne the precise role of the amino and carboxy termini of IkBa in signal-induced degradation of the protein. Our ®ndings show that simultaneous transfer of NH 2 and COOH IkBa terminal domains onto a b-gal substrate renders the chimeric proteins susceptible to inducible degradation by the proteasome in intact cells. The NH 2 terminus of the chimeric protein is modi®ed by phosphorylation and ubiquitination at the same residues as IkBa indicating that both substrates are modi®ed by similar, if not identical, mechanisms. More importantly, we show that in the absence of any other IkBa domain, the COOH domain exhibits the unique property not shared with the NH 2 terminus of targeting IkBa/b-gal proteins to the 20S catalytic core of the proteasome. This indicates that the COOH terminal end of IkBa mediates direct or indirect physical interaction with the catalytic core of the proteasome and thus determines the accessibility of the substrate for degradation.
Results
Simultaneous presence of both the NH 2 (aa 1 ± 70) and COOH (aa 251 ± 317) domains of IkBa are required to render an unrelated protein susceptible to TNF-induced degradation
To perform this analysis, we have generated chimeric IkBa/Escherichia coli b-galactosidase (b-gal) proteins. The choice of b-gal to investigate IkBa degradation signals was based on its well-known capacity to undergo rapid degradation upon modi®cation and destabilization by a variety of signals which render it highly sensitive to proteolytic attack. Indeed, the basal turnover of b-gal, a long-lived protein when expressed in eukaryotic cells, has been shown to be dramatically accelerated by addition of single amino acids at the NH 2 end (N-end rule substrate, Varshavsky, 1992) , the introduction of PEST sequences or ubiquitination signals (Hochstrasser and Varshavsky, 1990; Varshavsky, 1992) .
Chimeric IkBa/b-gal proteins were generated by fusing, individually or jointly, the NH 2 or COOH domains of IkBa to a modi®ed b-gal protein (Bachmair et al., 1986) . IkBa wild type (WT) sequences encompassing amino acids 1 ± 70 or 251 ± 317 were fused to the NH 2 or the COOH terminus, respectively, of the b-gal derivative to yield the chimeric proteins 1b through 4NbC, all of which carry a carboxy-terminal tag derived from simian virus 5 (SV5) (Hanke et al., 1992; Rodriguez et al., 1995) . A schematic representation of chimeric b-gal/IkBa proteins is shown in Figure  1a . It has previously been demonstrated that the presence of the SV5 tag does not alter the signalinduced degradation of IkBa either in vitro or in vivo . Electrophoretic migration patterns and antigenic characteristics de®ned by monoclonal antibodies directed against the NH 2 IkBa or the SV5 tag and a rabbit polyclonal antibody speci®cally recognizing the b-gal are shown in Figure 1b .
The susceptibility of dierent chimeric proteins to signal-induced degradation was analysed by transfecting the corresponding expression vectors into human embryo kidney 293 cells (Figure 2a ± c) . Forty-eight hours after transfection, cells were exposed to TNF for 30 min. Prior to induction cells were pre-incubated with cycloheximide (CHX) for 1 h to prevent new synthesis of IkBa which could interfere in the assessment of the stability of the pre-existent pool of protein. The stability of chimeric b-gal/IkBa was investigated by Western blot analysis. Our ®ndings show that neither the SV5 tagged b-gal alone (1b), nor the chimeras carrying the IkBa COOH or the NH 2 domain (2bC and 3Nb, respectively) were signi®cantly degraded following TNF induction for 30 min (Figures 2a and b) . The stability of these proteins was revealed by immunodetection with the polyclonal anti-b-gal antibody, which binds to epitopes in the core of the chimeras, and was con®rmed with either the anti-SV5 or 10B Mab antibodies which recognize the SV5 tag and IkBa NH 2 end, respectively ( Figure  2b ± d) . Thus, we con®rmed the apparent stability of the 1b, 2bC and 3Nb chimeras and ruled out the possibility that discrete proteolysis con®ned to IkBa domains or the tag epitope was taking place. In contrast to 1b, 2bC and 3Nb, the amount of the 130 kDa 4NbC chimera which contains both IkBa domains was drastically reduced upon exposure of transfected cells to TNF. TNF-induced proteolysis of 4NbC occurred simultaneously with degradation of the endogenous IkBa protein and was not cell type speci®c as the same phenomenon was also observed in human Jurkat T lymphocytes ( Figure 2d ). No 4NbC intermediates were detected (Figure 2a ± d) even when proteins were analysed in gels allowing optimal separation of high molecular weight polypeptides and blot probed with any one of the three antibodes described above (data not shown). The lack of 4NbC intermediates suggests a rapid destruction of intermediates or a highly processive mode of proteolysis which is compatible with the involvement of proteasome. It is important to note that degradation of bgal/IkBa chimeras requires the presence in cis of both IkBa NH 2 and COOH domains. Indeed, co-expression of b-gal/IkBa chimeras carrying either the amino-or the carboxy-terminus of IkBa from their respective DNA constructs did not render either of the two proteins susceptible to proteolyis (data not shown).
The peptide aldehyde Z-LLL-H (Rock et al., 1994 ) blocks proteasome-dependent degradation of IkBa promoted by TNF (Palombella et al., 1994; Ro et al., 1996) . To determine if the same proteolytic activity was also responsible for signal-inducible degradation of 4NbC, 293 cells transiently transfected with the 4NbC expression vector were pretreated with Z-LLL-H before TNF stimulation. Western blot analysis using the antitag and anti-b-gal antibodies ( Figure 3) shows that Z-LLL-H blocks the degradation of 4NbC in a fashion similar to that observed for endogenous IkBa ( Figure  3 ), indicating that the proteasome accounts for the proteolysis of the chimeric protein. Signal-induced degradation of IkBa is preceeded by modi®cation of its NH 2 terminal region Rodriguez et al., 1996) . Indeed, it is now well established that the induced phosphorylation of serines 32 and 36 during TNF stimulation is a prerequisite for ubiquitination of K21 and K22 and to a lesser extent of K38 and K47. These phosphorylated and ubiquitinated IkBa proteins are then degraded by the proteasome. The COOH terminal domain of IkBa encodes autonomous degradation signals which target either IkBa or unrelated substrates for in vitro degradation by the proteolytic activity of the proteasome
Since the IkBa COOH terminal region (aa 251 ± 317) is required for the degradation of the 4NbC chimera ( Figure 2 ) and IkBa (Brown et al., 1995; Whiteside et al., 1995; Sun et al., 1996; Beauparlant et al., 1996) , we sought to understand the role it might play in the degradation process of both proteins. The simplest hypothesis would be that this domain is required for either phosphorylation or ubiquitination events of the NH 2 domain required to make IkBa a substrate for the 26S proteasome. Although previous evidence tends to support the notion that the carboxy-terminus is not involved in (7) for an additional 30 min with 10 ng/ml of TNF. Cytoplasmic proteins from cell lysates were separated in SDS ± PAGE gels and blotted onto nitrocellulose ®lters. Blots in (a) and (b) were simultaneously probed with an anti-a-tubulin antibody to control the amount of protein load, and either the anti-b-gal or the anti-tag antibodies. In (c) TNF-induced degradation of the 3Nb, 4NbC and endogenous IkBa were compared. (d) Jurkat cells were transfected with either the 3Nb or 4NbC expression vectors induced with TNF and processed for Western blot analysis as described above. In (c) and (d) blots were probed with the 10B antibody which recognize an epitope located in the NH 2 terminus of IkBa the phosphorylation or ubiquitination of the NH 2 domain of IkBa , other ®ndings suggest that modi®cations aecting the carboxyterminal region could prevent accumulation of hyperphosphorylated forms of the protein in response to cell signals . We decided to ascertain whether large deletions aecting the IkBa COOH deleted protein could modify its capacity to undergo induced phosphorylation and ubiquitination. Using in vitro transcribed/translated radiolabelled proteins and a well-established cell-free system activated by okadaic acid, an NF-kB inducer , we show that both WT (aa 1 ± 317) and COOH-deleted IkBa (aa 1 ± 256) were phosphorylated and ubiquitinated as detected by the accumulation of well-de®ned, slow-migrating forms of IkBa and a
anti-α-tubulin IκBα-P IκBα-P Figure 5 The carboxy-terminal region of IkBa is dispensable for both signal-induced phosphorylation and ubiquitination of the NH 2 terminus. In vitro expressed COOH-terminally deleted (aa 1 ± 256) and full-length (aa 1 ± 317) IkBa proteins (WT and S32, 36A) labelled with 35 S-methionine were incubated at 378C with recombinant E1 and E2 enzymes, ubiquitin, ATP, OKA, and in the presence (+) or absence (7) of HeLa fraction II.3 (methods). Products were analysed by SDS ± PAGE and phosphorimaging. Phosphorylated forms of IkBa are indicated (IkBa-P) smear of high molecular weight proteins probably corresponding to covalent attachment of ubiquitin adducts ( Figure 5 ). As expected, and validating our interpretation, mutation of S32 and S36 residues (S32,36A mutant), which prevents both signal-induced phosphorylation and ubiquitination of IkBa, prevented the accumulation of hyperphosphorylated and ubiquitin-bound forms of the protein. In support of this result, in intact 293 cells we observed phosphorylation of the COOH-deleted IkBa mutant in response to TNF-induction (data not shown).
These ®ndings demonstrate that signal-induced modi®cations of the NH 2 terminal end of IkBa are independent of COOH terminal sequences. Furthermore, they suggest that the IkBa COOH terminal domain participates in the rapid, inducible degradation of the protein occurs at a post-ubiquitination step. Since COOH-deleted IkBa undergoes phosphorylation and ubiquitination in response to exogenous stimuli, it is likely that the role of the C terminus is either related to recognition of the 26S proteasome or that it modi®es the proteolytic activity of the 20S proteasome.
To test this hypothesis, we compared the capacities of recombinant WT and COOH-deleted IkBa to be degraded by highly puri®ed preparations of 20S proteasome complex obtained from rat liver. The 20S proteasome is a multi-protein complex that represents the catalytic core of the 26S proteasome and requires neither substrate ubiquitination nor ATP to degrade proteins in vitro, in contrast to 26S (reviewed in Coux et al., 1996) . Either WT or COOH-deleted IkBa recombinant proteins were incubated at 378C with puri®ed 20S proteasome (molecular ratio 2 : 1) for dierent lengths of time in phosphate buered saline (PBS). Proteins were separated under denaturing conditions, blotted and probed with the anti-IkBa 10B mab. Kinetic analysis of degradation (Figure 6b ) revealed a dramatic dierence in susceptibility of the two proteins to the 20S proteasome. While most of the IkBa WT was degraded after 10 min of incubation and became barely detectable 10 min later, the amount of COOH-deleted IkBa remained virtually unchanged throughout the experiment, and only a slight reduction was observed after the longest incubation time. The same susceptibility to proteolysis by the 20S complex was observed when IkBa proteins carrying combined mutation of ubiquitination sites K21R, K22R, K38R and K47R were incubated with the 20S proteasome (data not shown). Results described above were reproduced using two dierent batches of puri®ed 20S proteasome and IkBa proteins.
The possibility that the dierent susceptibilities of WT and COOH-deleted proteins to degradation in vitro could be due to a contamining proteolytic activity co-puri®ed with the IkBa WT was ruled out by con®rming that in the absence of proteasome preparations the amount of the WT protein remain unchanged throughout the experiment (Figure 6a ). IkBa WT proteolysis could be ®rmly ascribed to the proteolytic activity of the puri®ed 20S proteasome since incubation with the peptide aldeyde inhibitor Z-LLL-H prevented degradation (Figure 6b ), in contrast to the serine/cysteine protease inhibitor phenylmethylsulfonyl¯uoride (PMSF, 200 mM ®nal concentration) (data not shown) which blocks neither the proteolytic activity of the proteasome (Soddu et al., 1996) , nor in vitro degradation of IkBa by cytoplasmic extracts from TNF-activated cells . Overexposure of ECL blots containing IkBa proteins incubated with 20S proteasome in the presence of Z-LLL-H inhibitor, allowed identi®cation of IkBa degradation intermediates. However, these intermediates were recognized both by antibodies directed against the NH 2 and against the COOH-terminal tag of IkBa, suggesting that degradation by the 20S proteasome proceeds from either end of the protein (data not shown).
Interestingly, the capacity of IkBa terminal domains to target chimeric substrates for degradation by the proteasome in vitro was also observed when the IkBa/ b-gal fusion proteins were incubated with the puri®ed 20S proteasome complex. As observed in the experiments in intact cells, the simplest b-gal derivative carrying only the SV5 tag epitope (1b) appeared to be refractory to degradation in vitro. In contrast, the 4NbC chimera carrying both terminal ends of IkBa was eciently degraded by the 20S proteasome (Figure 7a ). More importantly, the lack of the IkBa NH 2 terminus in 2bC did not aect the susceptibility of the protein to be degraded by the 20S preparations. Indeed, 2bC was degraded with kinetics and eciency roughly similar to those of 4NbC. Incubation with the peptide aldehyde Z-LLL-H prevented degradation of chimeric proteins normally susceptible to the proteolytic activity of the 20S proteasome (Figure 7b ). In contrast to chimeric proteins carrying the COOH-terminal domain, the counterpart lacking this IkBa domain (3bN) was refractory to proteolysis. These ®ndings indicate that the NH 2 terminal domain of IkBa is not essential for proteolytic attack by the multisubunit complex containing the catalytic core of the proteasome. In IκBα ∆ COOH Figure 6 The COOH-terminal end of IkBa targets the protein for ubiquitin-independent proteolysis by the 20S proteasome. Equal amounts of either recombinant WT or COOH deleted (aa 1 ± 256) IkBa proteins carrying a SV5 epitope located at the carboxy-terminus were incubated for the indicated times with a rat liver puri®ed preparation of 20S proteasome in the presence or the absence of the Z-LLL-H proteasome inhibitor. The molar ratio IkBa:20S proteasome was 2 : 1. Degradation of IkBa was assessed by Western blot analysis using the anti-IkBa 10B antibody contrast, the IkBa COOH terminus acts as an autonomous degradation signal which enables recognition of the substrate by the catalytic core of the 20S proteasome and targets it for degradation.
Discussion
Our ®ndings demonstrate that simultaneous presence of IkBa NH 2 -or COOH-encoded degradation signals target an unrelated protein for degradation in intact cells and function independently of the ankyrin repeats which represent the structural core of the IkBa protein.
Thus, the NH 2 and COOH terminal domains of IkBa contain separate, non-redundant signals that require combined expression in cis to target substrates for proteasome-mediated degradation induced by cell activation. Our data and similar ®ndings (Brown et al., 1997) recently reported on proteins other than bgal, substantiate the capacity of the combined expression of NH 2 and COOH domains to function as a functional degradation unit with broad capacity to mark unrelated protein substrates for signal-induced degradation.
As for IkBa, degradation in intact cells of chimeric IkBa/b-gal carrying both IkBa terminal ends, requires phosphorylation and ubiquitination of the NH 2 terminal domain. Moreover, as shown in this work, the amino acid residues involved in both processes are the same for IkBa and IkBa/b-gal chimeras. This indicates that signal-induced modi®cation of both proteins operates through similar, if not identical, mechanisms. The primary role of the NH 2 terminal modi®cations undergone by IkBa upon cell signalling is to permit attachment of the ubiquitinated protein to the 26S proteasome, a function likely to be assured by interaction of the multichain of ubiquitin molecules with the 5S subunit of the proteasome integrated in the 19S regulatory complex (Deveraux et al., 1994) . However, from our ®ndings it can be deduced that ubiquitin-mediated attachment to the 26S proteasome is not sucient for proteolysis of either the IkBa derivative or the chimera lacking the COOH domain. This assumption is supported by the fact that in response to signal induction, the COOH terminally deleted IkBa is normally phosphorylated and ubiquitinated. Thus, on one hand, our ®ndings support the idea that induced post-translational modi®cation of the NH 2 domain occurs independently of the COOH tail of IkBa. On the other hand, they rule out the possibility that, in response to activation signals, abnormal modi®cation of the NH 2 domain of either the WT or chimeric IkBa/b-gal protein lacking the COOH terminus could account for the lack of sensitivity of these proteins to degradation by the proteasome. In conclusion, our ®ndings indicate that the role played by the COOH terminus in the inducible degradation of the protein takes place at a post-ubiquitination step.
More compelling evidence in support of a role for the COOH terminal end in a post-ubiquitination event is provided by the capacity of this domain, when fused to b-gal, to target the b-gal/IkBa chimera for degradation by the 20S proteasome. This property of the COOH terminal end, which is not shared by the NH 2 terminus of IkBa, reveals a unique ability of the COOH domain to provide a target for either interaction with and/or initial attack by, the catalytic core of the proteasome. The region of the COOH domain that could account for interaction and degradation by the proteasome remains to be identi®ed. One possibility is that the PEST sequence encoded in the COOH terminal domain of IkBa is recognized by the 20S proteasome complex. PEST sequences have been shown to be involved in the degradation of the yeast cyclin Cln3, a protein that is destabilized by cell growth or cell activation. Fusion of the COOH terminal domain of the Cln3 encoding a PEST sequence to a b-gal derivative marks the chimeric protein for inducible degradation by the Addition of the proteasome inhibitor Z-LLL-H inhibits degradation of the IkBa/b-gal chimeras by the 20S proteasome. In (a) and (b), the molar ratio chimera:20S proteasome was 2 : 1. The Z-LLL-H proteasome inhibitor was used at 100 mM ®nal concentration. Degradation of the chimeras was assessed by Western blot analysis using the anti-SV5 tag antibody proteasome (Yaglom et al., 1995) . In the case of IkBa, the role of PEST in signal-induced degradation is still controversial. Some reports pointed out that the IkBa PEST region is not required to target IkBa for signalinduced proteolysis (Van Antwerp et al., 1996b; Aoki et al., 1996; Sun et al., 1996) . In contrast, other observations indicate that removal of this region reduced the susceptibility of the protein to signalinduced degradation (Brown et al., 1995; Whiteside et al., 1995) . More consistent results have been obtained when the PEST region was deleted from IkBa along with other carboxy-terminal sequences. Consistent with this idea, removal of upstream sequences adjacent to PEST leads to an increased resistance of the protein to signal-induced degradation (Brown et al., 1995; Rodriguez et al., 1995; Whiteside et al., 1995; Chen et al., 1995; Sun et al., 1996; Beauparlant et al., 1996) . These ®ndings are compatible with the hypothesis that beyond the PEST region, other signals encompassed in the carboxy-end of the IkBa could also contribute to its destabilization upon cell activation by dierent stimuli. Thus, rendering the protein highly refractory to induced proteolysis would require removal not only of PEST, but also other degradation signals encoded in the carboxy-end of the protein. In contrast, transfer of one of the putative carboxy-terminal degradation signals, such as that encoded by the PEST region, would be sucient to target a substrate unrelated to IkBa but carrying the amino-terminus of IkB, for signal-induced proteolysis (Brown et al., 1997) . As a whole, our ®ndings are compatible with the hypothesis that the COOH terminal domain of IkBa is required to render the protein susceptible to proteolytic attack by the 20S proteasome, which represents the catalytic core of the 26S proteasome. A likely sequence of events is that phosphorylated and multiubiquitinated IkBa is recognized by the 19S regulatory component of the 26S proteasome and deubiquitinated by the associated isopeptidases. As a consequence of deubiquitination, IkBa may require an additional interaction with the 20S complex to be retained and processed eciently by the catalytic core of the proteasome. This function could be ful®lled by the COOH terminal end of IkBa and could require the presence of the highly acidic, negatively charged PEST. Whatever the precise mechanism underlying that capacity of the carboxy-terminus of IkBa, our findings support the hypothesis that the COOH terminal region represents a functional entity recognized by the 20S proteasome complex. One possibility now under investigation is that the carboxy-terminus of IkBa interacts with the 20S proteasome via chaperonin proteins, some of which have been described to copurify with proteasomes (Conconi et al., 1996) .
Materials and methods

Materials
The proteasome inhibitor carbobenzoxyl-leucine-leucineleucinal (Z-LLL-H) was synthesized as described previously (Fehrentz et al., 1985) and isolated by reversed-phase high performance liquid chromatography (495% purity). Its structure was con®rmed by NMR spectroscopy. Human recombinant TNF was provided by the MRC ADP reagent program. OKA was purchased from Sigma. The TSKgel DEAE-5PW column was from Tosohaas, the Mono Q HR5/5 column and the Superose 6 gel ®ltration column were from Pharmacia. N-t-Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin was purchased from SIGMA Chemical Co.
Plasmid construction of IkBa/b-gal chimeras
The pSb plasmid DNA (Clontech) was used as a polymerase chain reaction (PCR) template to obtain an (aa 8 ± 835) form of the E. coli b-gal protein. To produce a C terminal epitope-tagged version (`ctag') of this protein, its cDNA was inserted into BamHI cleaved pcDNA3 containing a 14 amino-acid epitope from the SV5 P protein (Hanke et al., 1992; Rodriguez et al., 1995) . N (aa 1 ± 70-and C (aa 251 ± 317)-terminal regions of IkBa were obtained by PCR ampli®cation using as templates the previously described IkBa WT ctag, S32/36A and K21/22/ 38/47R plasmid DNAs . The NH 2 and COOH terminal regions of IkBa were inserted into the ApaI-and BamHI/EcoRI sites of the pcDNA3-bgal-ctag plasmid, respectively. The identity of the constructs was con®rmed by dideoxy-sequencing of the plasmid DNAs (Sequenase).
In vitro expression of IkBa and IkBa/b-gal chimeric proteins
Transcription/translation of proteins was performed using 1 mg of plasmid DNAs and a wheat germ coupled transcription/translation system according to the instructions provided by the manufacturer (Promega). When radiolabeled proteins were generated, 35 S-methionine was used in the reaction.
Cell culture, transfections and degradation analyses COS-7, HeLa and human embryo kidney 293 cell lines were maintained in exponential growth in Dulbecco'smodi®ed Eagle's medium, containing 10% foetal calf serum and supplemented with penicillin and streptomycin. 50 ± 100 ng of plasmid DNAs were transfected for 16 h in subcon¯uent cells seeded in 25 cm 2 culture vessels using Lipofectace TM liposomes according to instructions provided by the manufacturer (Gibco). After transfection, cells were trypsinized, and aliquots were seeded in six-well plates and cultured for an additional 24 h. One hour before harvesting, the cells were incubated or not with 100 mg/ml of cycloheximide, and either induced with TNF (10 ng/ml) or left untreated for the last 30 min. Cytoplasmic fractions from treated cells were obtained after lysis in a hypotonic buer (50 mM NaCl, 10 mM HEPES pH 8.0, 500 mM sucrose, 1 mM EDTA, 0.2% Triton X-100) containing protease inhibitors (1 mM leupeptin, 1 mM pepstatin, 1 mM PMSF and 40 mg/ml bestatin) and centrifugation at 5000 g to sediment nuclei.
Western blot analysis
Cytoplasmic extracts (40 mg) were separated overnight by SDS ± polyacrylamide gel electrophoresis (SDS ± PAGE) (8%) and transferred onto nitrocellulose membranes (Sartorius) by semi-dry electroblotting. Anti-human IkBa (MAD3 10B) (Jaray et al., 1995) , anti-tag (SV5) monoclonal antibodies (Hanke et al., 1992) or anti-b-gal (Rockland) and anti-a-tubulin (Amersham) rabbit polyclonal antibodies were used for immunodetection of fusion proteins and endogenous control proteins. Immobilized antigen-antibody conjugates were detected with horseradish peroxidase-conjugated donkey anti-rabbit or antimouse immunoglobulins and an enhanced chemiluminescence detection system (ECL; Amersham).
In vitro phosphorylation/ubiquitination assay 35 S-methionine labeled in vitro transcribed/translated WT and COOH deleted IkBa proteins (0.5 ml) were incubated with 3 ml of HeLa cell fractions containing IkBa kinase activity in a 10 ml reaction mix including an ATP regenerating system (50 mM Tris pH 7.6, 5 mM MgCl 2 , 2 mM ATP, 10 mM creatine phosphate, 3.5 U/ml of creatine kinase and 0.6 U/ml of inorganic pyrophosphatase), ubiquitin (1 mg/ml), okadaic acid (3 mM), ubiquitin aldehyde (24 mg/ml), plant E1 (5 mg/ml), Glutathione-S-transferase-bound Ubch5 (40 mg/ml) and 2.5 mg/ml of recombinant Re1A. Reactions were incubated at 378C for 2 h. After terminating the reactions with 36 disruption buer, the reaction products were fractionated by SDS ± PAGE (8.5%) and the dried gels analysed by phosphorimaging.
Preparation of HeLa cells fractions
HeLa cell extracts were prepared by lysis in hypotonic buer containing 20 mM Tris pH 7.5, 1 mM EDTA, 1 mM DTT, phosphatase inhibitors (5 mM NaF, 1 mM Sodium Orthovanadate) and protease inhibitors (1 mM PMSF, 2 mM Benzamidine, 5 mg/ml leupeptin, 10 mg/ml pepstatin). Following incubation on ice for 15 min the cells were disrupted with a dounce homogeniser. After centrifugation at 40 000 r.p.m. for 30 min at 48C the supernatant was loaded onto a Q-sepharose column equilibrated with 50 mM Tris pH 7.5/0.5 mM DTT. The¯owthrough was collected (Fr I) and bound proteins were eluted stepwise with 0.1, 0.2, 0.3, 0.4 and 0.5 M KCl in 50 mM Tris pH 7.5/ 0.5 mM DTT (FrII.1 ± FrII.5). All fractions were further concentrated and fractionated by ammonium sulfate (40%) precipitation. After overnight dialysis against 50 mM Tris pH 7.5/0.5 mM DTT the fractions were stored at 7708C and used in the in vitro phosphorylation/ubiquitination assay.
Puri®cation of the 20S proteasome from rat liver
The 20S proteasome from rat liver was puri®ed as described in Friguet et al. (1994) . Brie¯y, after grinding of 40 g of rat liver in extraction buer (20 mM HEPES pH 7.8, EDTA 0.1 mM, 2-mercaptoethanol 1 mM), the homogenate obtained was subjected to two subsequent ammonium sulfate precipitations (35 and 60%). The pellet of the second precipitation was recovered and dissolved in resuspension buer (Tris-HCl 10 mM pH 7.2, KCl 100 mM, EDTA 0.1 mM, 2-mercaptoethanol 1 mM), against which it was also dialysed. The solution was applied to a DEAE-5PW ion exchange column and the bound protein eluted with a gradient of 100 ± 500 mM KCl.
The proteasome eluted at 400 mM KCl, and its activity was determined by a¯uorescent assay using as a substrate thē uorigenic peptide N-t-Boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin (LSTR-MCA), which is representative of the trypsin-like activity of the proteasome. The four fractions with the strongest activity were pooled, dialysed as described above and applied to a Mono Q HR5/5 anion exchange column. The proteasome eluted at 400 mM KCl in a gradient of 100 ± 500 mM KCl. The fractions with the strongest activity were applied to a Superose 6 gel ®ltration column. The proteasome eluted after the passage of 20 ml of potassium dihydrogen phosphate buer pH 7.0 with 100 mM KCl. When separated by SDS ± PAGE, only proteins with the expected molecular weight of the 20S proteasome subunits (in the range of 20 ± 30 kDa) plus a weak band corresponding to an apparent molecular mass of 90 kDa, likely copuri®ed HSP90 (Conconi et al., 1996) , were detectable by Coomassie staining.
In vitro degradation assays
Recombinant IkBa proteins (WT and COOH terminal deletion) were incubated at 378C with biochemically puri®ed rat proteasome (molar ratio substrate/proteasome, 2 : 1) for the periods of time indicated in the ®gures. As reaction buer, we used Phosphate Buered Saline. Reaction tubes were coated by exposure to dimethyldichlorosilane to prevent protein adhesion to the tube walls. The chimeric proteins were generated with the in vitro transcription/translation system described above, and cleared of debris, wheat germ proteasomes and ribosomal components by 3 h of centrifugation in a Beckman A-100/30 rotor at maximum speed to remove components with sedimentation coecients above 6 svedberg. Afterwards, samples were concentrated with an AMICON ®ltration system (size exclusion membrane of 100 kDa).
